Do you want to read an article? Please log in or register.
Does anti-tumor necrosis factor alpha prevent the recurrence of Crohn's disease? Systematic review and meta-analysis
Inflammatory Bowel Disease
Related content
RECOMMENDED
Inflammatory Bowel Disease
Early vs Late Use of Anti-TNFa Therapy in Adult Patients With Crohn Disease: A Systematic Review and Meta-Analysis
★ 2
Recommended by
Prof. Dr Stephan Vavricka, Faculty Member
Inflamm Bowel Dis.
Hamdeh S, Aziz M, Altayar O, Olyaee M, Murad MH, Hanauer SB
doi: 10.1093/ibd/izaa031.
Inflammatory Bowel Disease
Effect of Concomitant Therapy With Steroids and Tumor Necrosis Factor Antagonists for Induction of Remission in Patients With Crohn's Disease: a Systematic Review and Pooled Meta-analysis
Clin Gastroenterol Hepatol.
Faleck DM, Shmidt E, Huang R, Katta LG, Narula N, Pinotti R, Suarez-Farinas M, Colombel JF
doi: 10.1016/j.cgh.2020.06.036.
Inflammatory Bowel Disease
Real-world clinical effectiveness and safety of vedolizumab and anti-tumor necrosis factor alpha treatment in ulcerative colitis and Crohn's disease patients: a German retrospective chart review
BMC Gastroenterol.
Helwig U, Mross M, Schubert S, Hartmann H, Brandes A, Stein D, Kempf C, Knop J, Campbell-Hill S, Ehehalt R
doi: 10.1186/s12876-020-01332-w.
Inflammatory Bowel Disease
Comparative Risk of Serious Infections With Biologic and/or Immunosuppressive Therapy in Patients with Inflammatory Bowel Diseases: a Systematic Review and Meta-analysis
Clin Gastroenterol Hepatol.
Singh S, Facciorusso A, Dulai PS, Jairath V, Sandborn WJ
doi: 10.1016/j.cgh.2019.02.044.
Inflammatory Bowel Disease
Prediction of Relapse After Anti-Tumor Necrosis Factor Cessation in Crohn's Disease: Individual Participant Data Meta-Analysis of 1317 Patients From 14 Studies
Clin Gastroenterol Hepatol
Pauwels RWM, Janneke van der Woude C, Nieboer D, Steyerberg EW, Casanova MJ, Gisbert JP, Kennedy NA, Lees CW, Louis E, Molnár T, Szántó K, Leo E, Bots S, Downey R, Lukas M, Lin WC, Amiot A, Lu C, Roblin X, Farkas K, Seidelin JB, Duijvestein M, D'Haens GR, de Vries AC, CEASE Study Group.
doi: 10.1016/j.cgh.2021.03.037
Inflammatory Bowel Disease
Early Transmural Response Assessed Using Magnetic Resonance Imaging Could Predict Sustained Clinical Remission and Prevent Bowel Damage in Patients with Crohn's Disease Treated with Anti-Tumour Necrosis Factor Therapy
J Crohns Colitis.
Messadeg L, Hordonneau C, Bouguen G, Goutorbe F, Reimund JM, Goutte M, Boucher AL, Scanzi J, Reymond M, Allimant C, Dapoigny M, Pereira B, Bommelaer G, Buisson A
doi: 10.1093/ecco-jcc/jjaa098.
Inflammatory Bowel Disease
The relationship between endoscopic and clinical recurrence in postoperative Crohn's disease: a systematic review and meta-analysis
J Crohns Colitis
Ble A, Renzulli C, Cenci F, Grimaldi M, Barone M, Sedano R, Chang J, Nguyen TM, Hogan M, Zou GY, MacDonald JK, Ma C, Sandborn WJ, Feagan BG, Merlo Pich E, Jairath V
doi: 10.1093/ecco-jcc/jjab163
Inflammatory Bowel Disease
Relapse from deep remission after therapeutic de-escalation in inflammatory bowel disease: a systematic review and meta-analysis
J Crohns Colitis.
Zhang B, Gulati A, Alipour O, Shao L
doi: 10.1093/ecco-jcc/jjaa087.
Inflammatory Bowel Disease
No Benefit of Concomitant Immunomodulator Therapy on Efficacy of Biologics That are Not Tumor Necrosis Factor Antagonists in Patients With Inflammatory Bowel Diseases: a Meta-Analysis
Clin Gastroenterol Hepatol.
Yzet C, Diouf M, Singh S, Brazier F, Turpin J, Nguyen-Khac E, Meynier J, Fumery M
doi: 10.1016/j.cgh.2020.06.071.